Mercia announces significant contract for OXGENE
LONDON: Mercia Asset Management, the proactive, regionally focused specialist asset manager, confirmed that its portfolio company OXGENE, formally known as Oxford Genetics, has augmented its relationship with one of the world’s leading global life science companies, Abcam plc. This expanded…